Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SNDX-5613
SNDX-5613
Syndax looks to rebound from stinging late-stage failure, uncorking early data for next cancer drug up
Endpoints
Tue, 04/20/21 - 07:35 pm
Syndax Pharma
clinical trials
SNDX-5613
leukemia